Alferon(R) N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro

[GlobeNewswire] – PHILADELPHIA — Hemispherx Biopharma (NYSE MKT:HEB) announced that one of its advanced stage biological products, Alferon(R) N, significantly inhibited the replication of the MERS virus in vitro. MERS-CoV … more

View todays social media effects on HEB

View the latest stocks trending across Twitter. Click to view dashboard

See who Hemispherx is hiring next, click here to view